Swift Biosciences Amplicon HS Panels
Swift Biosciences has announced the early-access availability of its Swift Amplicon HS Panels, a high-sensitivity targeted amplicon library preparation kit for next-generation sequencing of liquid biopsy samples, including cell-free DNA. According to the firm, the panels allow detection and validation of mutations occurring at 0.25 percent to 3 percent frequency among a background of host samples.
The first kit being made available is Swift's EGFR Pathway Panel, which covers clinically relevant oncology hotspots including EGFR T790, KRAS G12/G13, NRAS Q61, and BRAF V600. The firm is also building custom panels and aims to release a Sample_ID panel for fetal/maternal tracing with the same sensitivity and specificity capability.